Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Target Price at $21.56

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have been given a consensus recommendation of "Hold" by the nine research firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $21.56.

OSCR has been the topic of a number of analyst reports. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective on the stock. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Piper Sandler reiterated an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Steven Wolin sold 19,580 shares of the company's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the sale, the chief operating officer now owns 102,598 shares of the company's stock, valued at $1,854,971.84. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. 25.11% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently bought and sold shares of the company. Raymond James & Associates acquired a new position in shares of Oscar Health in the second quarter valued at $3,168,000. Hennessy Advisors Inc. acquired a new stake in shares of Oscar Health during the second quarter worth $9,047,000. Catalyst Capital Advisors LLC bought a new position in Oscar Health during the 2nd quarter worth approximately $1,535,000. Bank of New York Mellon Corp raised its holdings in Oscar Health by 161.4% in the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock worth $22,038,000 after purchasing an additional 860,226 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Oscar Health by 26.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company's stock valued at $383,000 after acquiring an additional 5,138 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Stock Up 2.5 %

Shares of NYSE OSCR traded up $0.34 on Wednesday, hitting $13.84. The company had a trading volume of 306,946 shares, compared to its average volume of 3,459,194. The firm has a market capitalization of $3.42 billion, a P/E ratio of -225.00 and a beta of 1.63. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 12-month low of $7.75 and a 12-month high of $23.79. The business has a 50 day moving average of $16.14 and a two-hundred day moving average of $17.51.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company's revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.29) EPS. As a group, equities research analysts forecast that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.